Anti-CYP2A13 Antibody (aa454-484)
| Name | Anti-CYP2A13 Antibody (aa454-484) |
|---|---|
| Supplier | LifeSpan Bioscience |
| Catalog | LS-C167216 |
| Host | Rabbit |
| Clonality | Polyclonal |
| Applications | IHC-P WB FC |
| Species Reactivities | Human |
| Antigen | CYP2A13 antibody was raised against kLH-conjugated synthetic peptide from C-terminal region of human CYP2A13 |
| Blocking Peptide | CYP27 / CYP27A1 Antibody Blocking Peptide |
| Description | Rabbit Polyclonal |
| Gene | CYP2A13 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
Formalin-fixed and paraffin-embedded human breast carcinoma reacted with CYP2A13 Antibody , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.
Western blot of CYP2A13 Antibody in MDA-MB231 cell line lysates (35 ug/lane). CYP2A13 (arrow) was detected using the purified antibody.
CYP2A13 Antibody flow cytometry of MDA-MB231 cells (bottom histogram) compared to a negative control cell (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.